Division of Endocrinology, Department of Medical and Surgical Sciences, Alma Mater University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5651-5657. doi: 10.1210/jc.2018-02209.
Prolonged adrenal stimulation by corticotropin, as in long-standing Cushing disease (CD), leads to diffuse to nodular hyperplasia. Adrenal functional autonomy has been described in a subset of patients with CD, leading to the hypothesis of transition from ACTH-dependent to ACTH-independent hypercortisolism.
With the consideration that the catalytic α subunit of protein kinase A (PKA; PRKACA) somatic mutations are the most common finding in adrenal adenomas associated with ACTH-independent Cushing syndrome, our aim was to analyze PRKACA mutations in adrenals of patients with persistent/long-standing CD.
Cross-sectional.
University hospital.
Two patients with long-standing CD and suspicion of coexistence of autonomous adrenal hyperfunction, according to pre and postoperative evaluations, were selected for this study, following an intensive literature search and patient-chart reviewing.
Clinical data were analyzed. DNA was extracted from adrenal tissue for PRKACA sequencing. PKA activity was assayed.
PRKACA somatic mutations.
Both patients showed mutations of PRKACA in the macronodule in the context of micronodular adrenal hyperplasia. One patient harbored the previously described p.Leu206Arg substitution, whereas a p.Ser213Arg missense variation was detected in the adrenal nodule of the second patient. No mutations were detected in the adjacent adrenal cortex of the second patient. In silico analysis predicts that p.Ser213Arg can interfere with the interaction between the regulatory and catalytic subunits of PKA.
Our study shows that PRKACA somatic mutations can be found in adrenal nodules of patients with CD. These genetic alterations could represent a possible mechanism underlying adrenal nodule formation and autonomous cortisol hyperproduction in a subgroup of patients with long-standing CD.
促肾上腺皮质激素(ACTH)的长期刺激,如在长期库欣病(CD)中,会导致肾上腺弥漫性或结节性增生。在一部分 CD 患者中已经描述了肾上腺功能自主性,这导致了从 ACTH 依赖性向 ACTH 非依赖性皮质醇增多症转变的假说。
鉴于蛋白激酶 A(PKA)的催化α亚单位(PRKACA)体细胞突变是与 ACTH 非依赖性库欣综合征相关的肾上腺腺瘤中最常见的发现,我们旨在分析持续性/长期 CD 患者肾上腺中 PRKACA 突变。
横断面研究。
大学医院。
两名长期 CD 患者,根据术前和术后评估,怀疑同时存在自主肾上腺功能亢进,在进行了深入的文献检索和患者病历回顾后,选择了这两名患者进行本研究。
分析临床数据。从肾上腺组织中提取 DNA 进行 PRKACA 测序。测定 PKA 活性。
PRKACA 体细胞突变。
两名患者的大结节中均存在 PRKACA 突变,背景为微结节性肾上腺增生。一名患者携带先前描述的 p.Leu206Arg 取代,而第二名患者的肾上腺结节中检测到 p.Ser213Arg 错义变异。第二名患者的相邻肾上腺皮质未检测到突变。计算机分析预测 p.Ser213Arg 可能干扰 PKA 调节亚基和催化亚基之间的相互作用。
我们的研究表明,PRKACA 体细胞突变可在 CD 患者的肾上腺结节中发现。这些遗传改变可能是长期 CD 患者中肾上腺结节形成和自主皮质醇过度产生的潜在机制之一。